Ithaka Life Sciences client ProteinLogic awarded £1.2m grant by the Technology Strategy Board

Ithaka is pleased to announce that ProteinLogic, a biomarker discovery and exploitation company, Microtest Diagnostics, an in vitro diagnostic protein multiplexing company, and its collaborators have been awarded a grant by the government-backed Technology Strategy Board - the UK’s national innovation agency - to help support the development of MICROLOGIC™, a rapid point-of-care test for tuberculosis (TB). Ithaka’s founder and Managing Director, Dr Paul Rodgers, is Executive Chairman of ProteinLogic.
  Download - ithaka-press-release-131112.pdf